Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
JCO Precision Oncology|February 25, 2026
Safety of Multi-Omics-Guided Therapy in Advanced Melanoma: A Matched Comparative Cohort AnalysisBenedict Gosztonyi, Tarun Mehra, Gabriele Gut, et al.
NPJ Precision Oncology|December 16, 2025
Comparative cost analysis of a diagnostic multi-omics platform for decision support in advanced cancer - results from the Tumor Profiler Melanoma projectTarun Mehra, Dominik Menges, Benedict Gosztonyi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2025
Circulating tumor DNA is prognostic of patient outcome and enables therapy monitoring in metastatic uveal melanomaEgle Ramelyte, Julian Kött, Aleigha R Lawless, et al.
Clinical and Translational Radiation Oncology|October 13, 2025
First-in-human e-Flash radiotherapy using a modified conventional C-arm linear acceleratorJens von der Grün, Riccardo Dal Bello, Serena Psoroulas, et al.
Neoplasia (New York, N.Y.)|November 4, 2024
Patient recruitment into clinical studies of solid malignancies during the COVID-19 pandemic in a tertiary cancer centerJens von der Grün, Maiwand Ahmadsei, Isabel Breyer, et al.
Cancers|May 28, 2022
Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during LockdownLisa Kostner, Sara Elisa Cerminara, Gustavo Santo Pedro Pamplona, et al.
European Journal of Cancer (Oxford, England : 1990)|April 6, 2021
Sustainable responses in metastatic melanoma patients with and without brain metastases after elective discontinuation of anti-PD1-based immunotherapy due to complete responseFlorentia Dimitriou, Anne Zaremba, Clara Allayous, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
The genetic evolution of acral melanomaMeng Wang, Satoshi Fukushima, Yi-Shuan Sheen, et al.
Nature Communications|July 21, 2024
The genetic evolution of acral melanomaMeng Wang, Satoshi Fukushima, Yi-Shuan Sheen, et al.
European Journal of Cancer (Oxford, England : 1990)|May 22, 2026
Debio 0123, a WEE1 kinase inhibitor: Phase 1 results from dose escalation in patients with advanced solid tumorsKyriakos P Papadopoulos, Manish R Sharma, Reinhard Dummer, et al.
Pageof 6